IDSA and HIVMA Urge Bipartisan Congressional Intervention to Stop Medicare Cuts to 340B Hospitals

Infectious Diseases Society of America's picture


IDSA and HIVMA Urge Bipartisan Congressional Intervention to Stop Medicare Cuts to 340B Hospitals

The membership of the Infectious Diseases Society of America and the HIV Medicine Association are deeply concerned by the Centers for Medicare and Medicaid Services plan to cut 340B reimbursement for Medicare Part B drugs by nearly 30 percent for some participating hospitals. Set to take effect January 1, 2018, the payment cut will lead to an estimated $1.6 billion decrease in healthcare funding that will threaten healthcare access for uninsured and underinsured patients who can only count on these facilities. 

The 340B Drug Pricing Program allows hospitals and clinics to support patient services with 340B drug savings. With funding cuts, the ability to provide high quality care to low-income, vulnerable and underserved patients will be at risk. Participating academic medical centers across the country in the 340B program play a central role in providing HIV, viral hepatitis, and other infectious disease treatment and prevention services to patients without other care options. Because hospitals use these savings to fund additional frontline programs, such as substance use treatment, transitional housing, and other support services critical to confronting public health threats like the opioid and the HIV epidemics, we oppose funding decreases that target programs essential for our nation’s public health.  

IDSA and HIVMA urge Members of Congress to support bipartisan legislative efforts that would preempt the implementation of this provision and continue 340B payments to hospitals for Medicare Part B drugs at current rates. 


About IDSA
The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA’s purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.

About HIVMA   
HIVMA is an organization of nearly 5,000 clinicians and researchers whose professional focus is HIV medicine. HIVMA’s mission is to promote quality in HIV care by advocating policies and supporting programs that ensure a comprehensive and humane response to the AIDS pandemic informed by science and social justice. Nested within the Infectious Diseases Society of America, HIVMA's work includes creating clinical and educational tools and resources; supporting clinical training and research opportunities to build HIV workforce capacity; and promoting policies and programs to improve access to HIV prevention and care.

Copy this html code to your website/blog to embed this press release.


Post new comment

12 + 5 =

To prevent automated spam submissions leave this field empty.